96. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V ...

More documents

Recommendations

Info

L Lasitschka F. DO-046 Lehmann A. FR-031 Lehmann U. DO-117 Lehnen NC. FR-P-094 Leisten I. DO-045 Lenggenhager D. FR-001 Lennerz JK. FR-P-151, SO-042 Lenze D. SG-P-133, SG-147 Li XZ. SG-P-117, SG-133 Linge A. SO-037 Liu C. FR-P-160 Lohneis P. FR-P-152 Longerich T. FR-018 Löser H. DO-124, FR-P-165, SO-040 M Ma Y. SG-P-125, SG-138 Macher-Göppinger S. SO-073 Maegel L. DO-079 Mahajan V. SA-P-038, SA-P-063 Mairinger F. DO-114, FR-032 Majores M. SA-P-082 Malz M. FR-P-137 Marienfeld R. SA-P-056 Märkl B. SA-003 Marwitz S. FR-P-144 Marx AH. FR-P-039 May AM. DO-043, FR-P-159 Mehta AK. FR-P-100, SO-013 Meijer GA. VO-005 Menon R. FR-029 Menter T. DO-059, SA-P-096 Messner I. FR-P-082 Metzig M. FR-P-080 Meyer A-S. FR-026 Michels S. SO-015 Michl P. VO-031 Miehlke S. VO-010 Mietzsch F. DO-118 Mihic-Probst D. SA-002 Moch H. VO-018 Mogler C. FR-P-106 Mollenhauer M. DO-089 Mones D. FR-P-043 Morawietz L. DO-102 Mößinger K. SA-P-060 Muders M. SG-P-126, FR-P-089, SO-061, SG-139, VO-038 Mühling B. FR-P-123 Müller AM. SA-P-070, SA-P-074, SO-51, SO-055 Müller BM. SO-030 Müller S. DO-122 Münch C. FR-P-155 Munding J. DO-021 N Nelson PJ. SA-P-048 Nettersheim D. SO-068 Neumann J. SO-005 Neumann M. SO-043 Neumann M. SA-P-109 Neumann O. SO-011 Niendorf E. DO-064 Nitta H. FR-021 Noske A. SA-P-029 Nöthlings U. SA-P-111 O Ommer KS. DO-001a Omran H. ABS-888, SO-038 Ormanns S. DO-121 Otto M. FR-P121, FR-P-122 P Papadoupoulus N. VO-007 Papadopoulos T. FR-008 Pawlaczyk N. FR-P-169 Pelisek J. DO-101 Pellegrino R. DO-005 Perner S. VO-015 Perren A. VO-039 Petersen M. FR-P-054, FR-P-064, FR-P-101 Pfaltz K. SO-034 Pfister F. FR-P-125 Piscuoglio S. DO-022, FR-P-083 Poehlmann A. SO-002 Poremba C. DO-085 Porubsky S. SA-P-095 Q Quan P. SO-016 R Rao C. SG-P-123 Rao C. SG-P-116, SG-132 Rau TT. FR-P-069, FR-P-070 Rechsteiner M. FR-024 Reis H. SA-P-084 Reissig K. SA-P-052 Rennspiess D. DO-047 Rezaei M. VO-034 Ribback S. FR-P-110 Richter G. FR-010, SA-P-007 Richter P. DO-094 Riedl E. DO-044 Risio M. VO-001 Röcken C. VO-026 Rokahr J. SA-P-083 Rose M. FR-028 Rößler J. SA-P-037 Roßner M. DO-070 Roth W. VO-033 Rüping K. DO-082 Rupp NJ. SO-063 Rüschoff J. VO-040 S Sailer V. SA-P-076, SO-057 Schaefer I-M. FR-P-061, FR-P-063 Scharbatke EC. FR-P-052 Scharenberg C. DO-092 Scheil-Bertram S. SA-P-020 Schierle K. FR-P-062 Schildgen V. SA-P-035 Schildhaus H-U. DO-035 Schirmacher P. DO-036 Schmauder M. SA-P-107 Schmidt J-A. DO-066 Schmidt R. DO-075 Schmitt B. SA-P-036 Schmitz-Rixen T. DO-099 Schnabel PA. FR-P-139 Schneider N. FR-P-072 Schneider J. DO-084 Schneider-Stock R. FR-007 Schöne C. SA-P-013 Schoner K. SA-P-075, SO-056 Schöpfer A. VO-012 Schrader T. DO-001b, DO-074, SA-P-104 Schrader C. DO-050, DO-053, FR-P-077, FR-P-084, FR-P-085, FR-P-088, FR-P-153, FR-P-158 Schramm M. FR-P-111 Schröck E. FR-022 Schröder J. SA-P-098 Schultz H. FR-P-130 Schuster C. DO-116 Schwertheim S. FR-P-178, FR-P-179 Seitz V. DO-061 Senft E. DO-090 Shaikhibrahim Z. SO-062 Siegmund B. VO-008 Simon E. FR-P-108 Simon F. DO-104 Simon-Keller K. SO-046 Sinn BV. SO-008 Sinn H-P. SO-024 Sipos B. VO-029 Slotta-Huspenina J. FR-P-040 Söder S. FR-P-176 Soltermann A. FR-020 Spilka R. SA-P-085 Steffen JS. FR-P-051 Steiner T. SO-071 Steinhilber J. DO-065 Stenzinger A. DO-088 Sterlacci W. DO-026 Stöhr R. FR-016 Stomper J. SO-064 Straub M. DO-083 Szczepanowski M. FR-P-148 T Tannapfel A. VO-030 Teller A. FR-P-045 Thies SA. FR-P-044 Thorns C. DO-054 Tiede C. DO-095 Timme S. DO-015, SA-P-008 Tindall DJ. VO-027 Tischler V. SG-P-131, SG-145 Titze U. SA-P-072, SO-053 Tóth C. FR-P-166 Trapani F. SO-004 Troidl K. DO-100 Tzankov A. DO-058, DO-060 U Ullrich A. VO-014 V Varga Z. SA-P-005, SO-026 Veits L. FR-P-038 Venkataramani V. SA-P-065 Verdoodt B. SA-P-080 Vlajnic T. FR-P-046 Vogel UF. FR-P-127 Vogetseder A. SA-P-057 Vogt M. SG-P-127, SG-140 Vogt N. DO-052 Vokuhl C. SO-048 Vollmer E. DO-025 von Laffert M. FR-015 von Winterfeld M. FR-P-067 W Wachter DL. FR-P-096 Wagner S. FR-034 Walluks K. SA-P-061 Walther B. FR-P-177 Wang L. SG-P-121 Wang X. FR-P-145 Wardelmann E. SA-P-041, VO-017 Warneke V. FR-023 Warth A. DO-028, DO-029, FR-P-135, FR-P138, FR-P-140 Wassilew K. DO-106 Weber A. FR-P-049 Weiler C. DO-096 Weinberg RA. VO-032 Wenke A-K. SA-P-044 Westphal S. FR-P-161 Wethkamp N. SA-P-050 Wieczorek K. SA-P-069, SO-050 Wielockx B. FR-P-157, VO-036 Wienert S. SA-P-105 Winkler J. DO-002a Wirtz R. SO-067 Wölfel C. FR-P-175 Wötzel F. FR-P-142 Wuensch T. FR-P-073 Wulf L. SO-044 Wyler-von Ballmoos L-G. SO-074 X Xu J. SA-P-059 Xu J. SG-P-122 Y Yasui W. VO-025 Ye M. SA-P-046 Z Zeiske T. FR-P-146 Zeng Y. SG-P-118, SG-134 Zerbe N. DO-067, DO-071, DO-072 Zhang J. SG-P-124, SG-137 Zhang W. SG-P-120, SG-142 Zhang X-x. FR-P-150 Zimmermann A-K. SA-P-022 Zimpfer A. FR-009 Der Pathologe · Supplement 1 · 2012 | 175
Rudolf-Virchow-Preis Ausschreibung 2013 Der Preis wird laut Satzung der Rudolf-Virchow-Stiftung und der Deutschen Gesellschaft für Pathologie einem Pathologen unter 40 Jahren für eine noch nicht veröffentlichte oder eine nicht länger als ein Jahr vor der Bewerbung publizierte wissenschaftliche Arbeit verliehen . Die Verleihung des Preises erfolgt auf der 97 . Jahrestagung der Deutschen Gesellschaft für Pathologie e . V . 2013 . Zusammen mit einem Lebenslauf und einer Publikationsliste reichen Bewerber ihre Arbeit ein . (Bitte alle Unterlagen in doppelter Ausfertigung sowie elektronisch einreichen!) Abgabetermin: bis zum 31. Dezember 2012 Einzureichen bei: Prof . Dr . med . Holger Moch Geschäftsführendes Vorstandsmitglied der Deutschen Gesellschaft für Pathologie e .V . UniversitätsSpital Zürich Institut für Pathologie Schmelzbergstrasse 12 CH – 8091 Zürich Deutsche Gesellschaft für Pathologie e . V . – Vorstand – Frühjahr 2012 © neumann-meding
Page 2 and 3:
Inhalt Der Pathologe · Supplement
Page 4 and 5:
Inhalt Der Pathologe · Supplement
Page 6 and 7:
Editorial Liebe Kolleginnen und Kol
Page 8 and 9:
Kolorektales Karzinom 2 VO-005 Tran
Page 10 and 11:
Keynote Lecture VO-014 Genetic dete
Page 12 and 13:
(AMACR, FASN, GOLM1, GSP-pi, ERG) t
Page 14 and 15:
to assess the correct rate of R1 re
Page 16 and 17:
DNA damage, and cytotoxic drugs. Au
Page 18 and 19:
HCV-positive formalin-fixed and par
Page 20 and 21:
well as MET activation were examine
Page 22 and 23:
or BRAF mutation, c-MYC and SIRT1 e
Page 24 and 25:
AG Pneumopathologie III DO-032 Remo
Page 26 and 27:
immature granulopoiesis showed a st
Page 28 and 29:
ned, if well-defined mantle zones,
Page 30 and 31:
phomas). Most prominent gains or am
Page 32 and 33:
DO-062 Tumor-associated macrophages
Page 34 and 35:
DO-080 DOG1: an immunohistochemical
Page 36 and 37:
AG Oralpathologie DO-087 Detection
Page 38 and 39:
DO-094 Do activated fibroblasts inf
Page 40 and 41:
DO-101 Histopathological analysis o
Page 42 and 43:
DO-108 Identification of potential
Page 44 and 45:
Conclusions. In conclusion, 454 par
Page 46 and 47:
subgroup of patients with B-Raf mut
Page 48 and 49:
DO-002b Impact of terminologies in
Page 50 and 51:
Methods. We performed MCPyV-FISH of
Page 52 and 53:
FR-013 HPV-genotype distribution in
Page 54 and 55:
Methods. Three different techniques
Page 56 and 57:
(i.e. investment in equipment and e
Page 58 and 59:
FR-032 COLD-PCR: a powerful tool in
Page 60 and 61:
dissection (MBLND) technique to imp
Page 62 and 63:
SO-005 Prevalence of mutations in s
Page 64 and 65:
SO-011 Methylation profiling and in
Page 66 and 67:
more effective than SAHA alone and
Page 68 and 69:
SO-022 Specialized pathology review
Page 70 and 71:
SO-027 Ki-67 in mitotic score group
Page 72 and 73:
nificantly associated with advanced
Page 74 and 75:
liver did not correlate with the mu
Page 76 and 77:
AG Paidopathologie II SO-046 Overex
Page 78 and 79:
Results. Histomorphology of the ova
Page 80 and 81:
p42 and p27 have not yet been inves
Page 82 and 83:
SO-068 Recent advances in understan
Page 84 and 85:
SO-075 A novel, dual role of CCN3 i
Page 86 and 87:
Pancreatic Adenocarcinoma SG-137 Se
Page 88 and 89:
sease and 30 colon cancer serum sam
Page 90 and 91:
Conclusions. Although CRC is charac
Page 92 and 93:
differentiated and TNM stage III or
Page 94 and 95:
pressed moderate levels of the prot
Page 96 and 97:
FR-P-037 MALDI imaging reveals COX7
Page 98 and 99:
in the context of therapy response
Page 100 and 101:
on primary cells of wild-type and c
Page 102 and 103:
chemotherapy was recommended and co
Page 104 and 105:
aims are twofold: 1) to verify the
Page 106 and 107:
Results. Her2/neu status in TMAs an
Page 108 and 109:
prognostic impact was found in rect
Page 110 and 111:
provided information on survival ti
Page 112 and 113:
Methods. Biopsy specimens from 430
Page 114 and 115:
the OS rate was 53% for patients wi
Page 116 and 117:
FR-P-098 Immunohistological stainin
Page 118 and 119:
FR-P-104 Histopathological evaluati
Page 120 and 121:
within the earliest morphologic det
Page 122 and 123:
Conclusions. In primary imaging a g
Page 124 and 125:
fibrotic neointma development as we
Page 126 and 127: FR-P-129 Alpha-1-antitrypsin-PiZ-an
Page 128 and 129: FR-P-136 The expression of central
Page 130 and 131: cosa and in the periarterial tissue
Page 132 and 133: FR-P-149 Combination of Castleman d
Page 134 and 135: or without different concentrations
Page 136 and 137: Results. In 18 cases (79%) the caus
Page 138 and 139: FR-P-168 Autopsy findings in a 2-ye
Page 140 and 141: FR-P-174 MPGN-like glomerulonephrit
Page 142 and 143: Poster: Gynäkopathologie und Mamma
Page 144 and 145: SA-P-011 Genetic aberrations of pre
Page 146 and 147: Mechanismen, die eine Progression d
Page 148 and 149: internet server. A network of inter
Page 150 and 151: Methods. HE-gefärbte Schnittpräpa
Page 152 and 153: Conclusions. The newly released 450
Page 154 and 155: and desmoplastic reaction are diffe
Page 156 and 157: one patient revealed more than 9 mi
Page 158 and 159: situation, the V600E mutation in th
Page 160 and 161: SA-P-064 Evolution of molecular pat
Page 162 and 163: nic markers such as myf4 and MyoD1
Page 164 and 165: Conclusions. To our knowledge, this
Page 166 and 167: SA-P-085 Expression of the eukaryot
Page 168 and 169: Results. The papillary RCC type II
Page 170 and 171: SA-P-098 Male infertility: assessme
Page 172 and 173: SA-P-104 Process oriented scientifi
Page 174 and 175: Conclusions. The IBDW offers a uniq
show all

96. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?